Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Clinical trial NCT07080905 · RECRUITING
Trial details
- NCT number
- NCT07080905
- Sponsor
- CSL Behring
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2033-10-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.